Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

Also called NCT02932436

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02932436
  • EudraCT 2016-001264-11
Other papers using this trial's data
  • Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial Cardiovascular diabetology, 2025-09-08 DOI, PubMed 40922034, PMC12418620 In the PMC Open Access subset under CC BY.
  • Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus-results from the randomized, double-blind, placebo-controlled EmDia trial Clinical research in cardiology : official journal of the German Cardiac Society, 2023-07 DOI, PubMed 36763159, PMC10293456 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02932436. Randomized; quadruple masking; primary purpose treatment. Start 2016-10-10 (actual); primary completion 2020-06-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
Acronym
EmDia
Condition
Diabetes Mellitus, Type 2
Condition
Diastolic Dysfunction
Intervention (Drug)
Empagliflozin
Intervention (Drug)
Placebo
Lead sponsor
Johannes Gutenberg University Mainz (class: other)
Collaborator
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct02932436
Content hash
2c456aa51df8710cd7abe6d826d9b0393f9c95577ca8358bfa96d5b2fc25c1e0